Description

BENZTETRA 25 contains the active ingredient tetrabenazine 25mg, a medication used to treat the chorea ( a movement disorder) that is caused by Huntington disease. Primarily, it is prescribed to control involuntary, jerky, or uncontrollable movements, commonly referred to as chorea, which are seen in diseases like Huntington’s disease. Tetrabenazine 25mg works by regulating neurotransmitter activity in the brain, particularly by reducing excess dopamine, serotonin, norepinephrine, and other chemical messengers, which are involved in causing these abnormal movements. This regulation helps patients regain better control over their muscle function and movement patterns, greatly improving daily living and reducing distress associated with these disorders. BENZTETRA 25 is critical in offering symptomatic relief but does not cure the underlying disease itself. What is BENZTETRA 25? BENZTETRA 25 is a pharmaceutical tablet containing tetrabenazine 25mg, classified as a vesicular monoamine transporter 2 (VMAT2) inhibitor. This mechanism reduces the release of certain neurotransmitters in the brain that trigger involuntary muscle movements. It is mainly used in the management of hyperkinetic movement disorders where control over muscle movement is impaired. Uses of BENZTETRA 25 To treat chorea (a movement disorder) that is caused by Huntington disease. Management of abnormal involuntary movements associated with neurological disorders such as tardive dyskinesia and other hyperkinetic conditions. Helps reduce sudden, uncontrolled, and jerky movements, improving patient mobility and quality of life. May be used as prescribed for other movement disorders involving excessive neurotransmitter activity. Side Effects of BENZTETRA 25 Common side effects include drowsiness, fatigue, insomnia, and nausea. Patients may experience mood changes such as depression or anxiety. Possible movement-related side effects can include tremors or Parkinsonism-like symptoms (rigidity, slow movement). Rare but serious side effects include suicidal thoughts, heart rhythm disturbances, or neuroleptic malignant syndrome (characterized by fever, muscle stiffness). Gastrointestinal discomfort like vomiting or abdominal pain may also occur. Precautions Before Using BENZTETRA 25 Inform your doctor if you have a history of depression, suicidal ideation, or any psychiatric illness. Avoid use if you have severe liver disease or have recently taken monoamine oxidase inhibitors (MAOIs), as dangerous interactions can occur. Use caution while driving or performing tasks requiring alertness due to possible drowsiness or dizziness. Do not abruptly stop taking the medication without consulting your healthcare provider, as symptoms may worsen. Regular monitoring by your physician is necessary to watch for mood changes or adverse neurological effects. Drug Interactions – What Drugs Interact with BENZTETRA 25? Avoid concurrent use with MAO inhibitors (e.g., phenelzine, selegiline), as this may cause severe and dangerous reactions. Medications affecting the central nervous system (like antidepressants, antipsychotics) may increase the risk of side effects or alter therapeutic effects. Drugs that prolong the QT interval (certain heart medications) may enhance cardiac risks when taken with tetrabenazine. Inform your healthcare provider about all medicines you are taking, including over-the-counter drugs and supplements, to avoid interactions. Conclusion BENZTETRA 25, containing tetrabenazine 25mg, is an essential treatment option for controlling involuntary movements, particularly chorea caused by Huntington disease. It works by modulating neurotransmitter levels in the brain to reduce abnormal muscle activity. While it helps significantly in managing symptoms, careful attention to dosing, side effects, and potential drug interactions is crucial to ensure safe and effective treatment. Always consult healthcare professionals for personalized advice and follow prescribed instructions for optimal results.